Mortality after implantable cardioverter defibrillators in dialysis patients: a nationwide study

1 September 2020 (08:30 - 08:30)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Amna Alhakak

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

7 More presentations in this session

Presentation thumbnail

Long-term follow-up of patients with tetralogy of Fallot and implantable cardioverter defibrillator

Doctor V. Waldmann (Paris, FR)

Abstract Slides Video

Presentation thumbnail

Change in QRS area by cardiac resynchronization therapy is associated with clinical outcomes and echocardiographic response

Mr M. Ghossein (Maastricht, NL)

Abstract Slides Video

Presentation thumbnail

Risk factors for mortality within one-year after implantable cardioverter defibrillator implantation: a nationwide study

Miss A. Alhakak (Copenhagen, DK)

Abstract Slides Video

Presentation thumbnail

Relationship between mortality after ICD implantation and center volume in Belgium

Mr R. Hoffmann (Leuven, BE)

Abstract Slides Video

Presentation thumbnail

Automated screening tool for Subcutaneous Implantable Defibrillator in Brugada syndrome has a high eligibility rate which is predicted by simple electrocardiographic parameters

Mr S. Marelli (Pavia, IT)

Abstract Slides Video

Access the full session

Session thumbnail

Outcomes with Cardiac Implanted Electronic Devices and Their Follow-Up

The Event

ESC Congress 2020

1 September 2020 08:30 CET

You may be interested in

Congress Session

Debate on primary prevention in ICD therapy

Congress Session

Implantable cardioverter defibrillator therapy

Congress Session

Hot topics in the management of ventricular tachycardia and sudden cardiac death

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources